Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen
Stock Information for Atossa Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.